Effectiveness and safety of Mizoribine for the treatment of IgG4-related Disease: A Retrospective Cohort Study.

Published: Mar 16, 2021
Abstract
OBJECTIVE Patients with IgG4-Related Disease (IgG4RD) usually require steroid-sparing agents due to relapse with tapering glucocorticoids (GC). The aim of this study was to determine the efficacy and safety of Mizoribine (MZR) among IgG4RD, which inhibits inosine monophosphate dehydrogenase, a rate-limiting enzyme in the de novo pathway of purine synthesis. METHODS We retrospectively reviewed records of IgG4RD patients at the Immuno-Rheumatology...
Paper Details
Title
Effectiveness and safety of Mizoribine for the treatment of IgG4-related Disease: A Retrospective Cohort Study.
Published Date
Mar 16, 2021
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.